pharmaphorum
DECEMBER 21, 2021
Sanofi has bolstered its immuno-oncology pipeline with a $1 billion agreement to acquire Amunix Pharma of the US – its fourth bolt-on deal of 2021. South San Francisco-based Amunix specialises in T-cell engager and cytokine-based treatments for solid tumours, and is planning to advance its lead programme AMX-818 – a cell-based therapy which targets HER2-expressing cancers – into the clinic next year.
Fierce Healthcare
DECEMBER 21, 2021
More than 40 organizations, unions urge OSHA to extend protections for healthcare workers. agliadkovskaya. Tue, 12/21/2021 - 15:57.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
DECEMBER 21, 2021
In early 2020, health officials were cautious about forecasting a COVID-19 vaccine timeline to the public, as vaccine discovery was a historically laborious process that took years (if not decades). Yet a successful COVID-19 vaccine gained emergency approval in just 11 months, a blistering pace that likely saved millions of lives. Such a fast turnaround would not have been possible without advanced analytics and the troves of intelligence that scientists had at their disposal.
Fierce Healthcare
DECEMBER 21, 2021
2022 forecast: Investors will double down on these hot digital health markets. hlandi. Tue, 12/21/2021 - 16:45.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Outsourcing Pharma
DECEMBER 21, 2021
The organization is working to give oncology professionals the chance to hear directly from patients about their unique experiences, concerns, and hopes.
Fierce Healthcare
DECEMBER 21, 2021
Digital health startups join HHS accelerator to tackle COVID health inequities. rtorrence. Tue, 12/21/2021 - 11:06.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Fierce Healthcare
DECEMBER 21, 2021
CMS: Medicaid, CHIP enrollment increases by 433K in June and 17% since start of pandemic. rking. Tue, 12/21/2021 - 12:36.
pharmaphorum
DECEMBER 21, 2021
Novartis has joined the ranks of big pharma companies developing TIGIT-targeted drugs for cancer, and found its candidate in an existing partner, Chinese biotech BeiGene. The Swiss pharma group is paying BeiGene $300 million upfront for an option on ociperlimab, a TIGIT antibody in phase 3 testing for non-small cell lung cancer (NSCLC), with another $700 million on offer if that option is exercised before 2023.
Fierce Healthcare
DECEMBER 21, 2021
More than 800 hospitals urge HHS to appeal controversial ruling in 340B lawsuit. rking. Tue, 12/21/2021 - 14:13.
pharmaphorum
DECEMBER 21, 2021
Welsh medtech company Bond Digital health has raised £1 million ($1.3 million) in additional funding for its data capture and management system for lateral flow tests (LFTs). The Cardiff-based company said it will use the new money to expand its headcount, including hiring a new customer service team, and adding to its sales, marketing and product development departments.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
DECEMBER 21, 2021
Burnout, workload and fear of infection compel physicians and nurses to reduce hours or leave, study finds. hlandi. Tue, 12/21/2021 - 09:56.
PharmD Live
DECEMBER 21, 2021
1. Fee-for-service reimbursement falls as quality performance pay increases. A 3.75% cut in the 2022 Medicare conversion factor, which calculates reimbursement for procedures under fee-for-service, is mandated under a budget neutrality provision and comes after a pay bump from Congress that expires in 2022. Meanwhile, quality performance pay is increasing.
Fierce Healthcare
DECEMBER 21, 2021
Biden to announce free home COVID testing, emergency hospital support to head off winter omicron surge. dmuoio. Tue, 12/21/2021 - 12:16.
Psychadelic Pharmacist
DECEMBER 21, 2021
In the first installment of the Psychedelic Pharmacist Interview Series, Dr. Kelan Thomas speaks with Psychedelic Pharmacists Association co-founder Dr. Michael Haichin about his unique career path, the future of psychedelics in pharmacy, and more. See below for additional show notes. Dr. Kelan Thomas, PharmD, MS, BCPP, BCPS is an Associate Professor of Clinical Sciences … Psychedelic Pharmacists Interview Series: Dr.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
pharmaphorum
DECEMBER 21, 2021
GlaxoSmithKline’ majority-owned HIV unit ViiV has scored a key FDA approval, getting approval for its long-acting drug cabotegravir as the first injectable for pre-exposure prophylaxis (PrEP) –challenging market leader Gilead Sciences. Cabotegravir – given the trade name Apretude – can be dosed just six times a year and showed superior results to daily, oral therapy with Gilead’s widely used Truvada (emtricitabine and tenofovir disoproxil fumarate) in a head-to-head trial.
Outsourcing Pharma
DECEMBER 21, 2021
This monthâs collaborations, tech partnerships, new facilities, and other happenings includes news from Flywheel, Medable, Veeva, and other organizations.
Fierce Healthcare
DECEMBER 21, 2021
Mentorship plays a key role in advancing careers for physicians underrepresented in medicine: report. hlandi. Tue, 12/21/2021 - 10:51.
Outsourcing Pharma
DECEMBER 21, 2021
A leader from Oracle Health Sciences shares insights on how drug development and research pros collaborated to overcome formidable challenges this year.
Pharma Times
DECEMBER 21, 2021
The DETERMINE trial aims to discover whether existing ‘licensed’ drugs could also benefit patients with rare cancer types that the drug is not currently licensed for.
The Physician Pharmacist
DECEMBER 21, 2021
Amassed from a large collection of pharmacy student/graduates from all different walks of life! I have have compiled the 6 most common questions and provided my short answers for direction. No lengthy introduction needed, let's dig in! 1. "Why did you want to go to medical school after pharmacy school?". This is by far the most commonly asked interview question any pharmacy applicant will receive.
Pharma Times
DECEMBER 21, 2021
With approval, Saphnelo would be the first available treatment for systematic lupus erythematosus in Europe in over ten years.
Expert insights. Personalized for you.
124 
Let's personalize your content